- Trade war worries loom over Las Vegas tech show
- America mourns former president Jimmy Carter at state funeral
- Djokovic handed tough Australian Open draw, Sinner faces Jarry test
- Bok prop Nche wary of Dupont threat in Champions Cup
- Conceicao brings good vibes back to AC Milan after Super Cup triumph
- 'We have lost everything': Despair in the Los Angeles fires
- Australia frets over Meta halt to US fact-checking
- Japan startup hopeful ahead of second moon launch
- Ukraine allies to hold last defence meet before Trump takes office
- NBA-best Cavs win 11th in a row to end 15-game Thunder streak
- What you need to know about HMPV
- Venezuela braces for crunch anti-Maduro protests
- Bangladesh garment industry rebounds, but workers say little change
- Asian markets drop as trades fret over US inflation, rates outlook
- Mozambique opposition leader due home amid tension over disputed vote
- Doping and a match made in heaven: Australian Open storylines
- Australia recall McSweeney for Sri Lanka Tests, Connolly set for debut
- Myanmar military adopts anti-junta fighters' drone tactics
- Lebanon set to finally elect president after two-year vacancy
- New twist in US-Cuba trademark fight over Havana Club rum
- CES tech looks to help world's aging population
- Venezuela repression increases ahead of crunch anti-Maduro protests
- Rubber tappers forge sustainable future in Amazon
- 'No more fires,' demand fed-up Amazon residents
- Assault on Chad presidential complex leaves 19 dead
- Crowds throng as Jesus statue parades through Philippine capital
- Slot fumes after Spurs teenager Bergvall avoids red card to sink Liverpool
- Fighting at Chad presidency leaves 19 dead, several injured
- US astronauts upbeat seven months into eight-day mission
- Bergvall strikes as Spurs snatch League Cup semi-final lead over Liverpool
- Extreme weather, suburban sprawl fuel LA's wildfires
- Campaigners fear spike in hate speech as Meta lifts restrictions
- Yakuza leader pleads guilty in US court to conspiring to sell nuclear material
- Barcelona defeat Bilbao without Olmo to reach Spanish Super Cup final
- Displaced LA residents in shock at scale of fire destruction
- Gunfire erupts inside presidency in Chad capital
- Miami and Tampa to host outdoor NHL contests in 2026
- Popov claims first World Cup win in Madonna di Campiglio slalom
- Tottenham star Bentancur 'conscious' after head injury in Liverpool clash
- NHL Kings postpone game while NFL monitors LA area wildfires
- Barcelona defeat Athletic without Olmo to reach Spanish Super Cup final
- Bulgaria's Popov claims first World Cup win in Madonna di Campiglio slalom
- Niemann and Nicolai Hojgaard accept special Masters invitations
- Political chess or true beliefs? Zuckerberg's surprise Trump pivot
- Hosszu, swimming's 'Iron Lady', retires at 35
- US withholds $3.6 mln payment to WADA after no audit
- Venezuela opposition decry crackdown before Maduro swearing-in
- US Fed officials concerned over 'stalled' disinflation, tariffs: minutes
- Whole streets burn as fires rage around Los Angeles
- Celebrities flee Los Angeles fires as Hollywood events scrapped
US labels 'tranq' drug linked to fatal overdoses as 'emerging threat'
The US government on Wednesday designated xylazine, commonly known as "tranq," as an "emerging threat" and asked Congress for funding to fight the drug that has been increasingly linked to a surge in overdose deaths.
"This is the first time in our nation's history that a substance is being designated as an emerging threat by any administration," said Rahul Gupta, director of the White House Office of National Drug Control Policy.
Xylazine is an animal tranquilizer that is typically used by veterinarians to sedate large animals such as horses and deer.
It is not approved for use in humans but is commonly mixed with fentanyl, cocaine or heroin and is known by the street name "tranq," according to the US Drug Enforcement Administration (DEA).
Consumption of xylazine can lower one's blood pressure and heart rate to critically low levels and can cause skin ulcers and abscesses that can lead to amputation.
Gupta said the federal government will publish a plan within 90 days on ways to combat the overdose scourge caused by xylazine, also known as the "zombie drug."
The plan would look at increasing testing capacity, withdrawal management, treatment protocols and attacking the supply chain of illicit xylazine, he said.
"President Biden remains committed to beating the overdose crisis," Gupta said. "We need support from Congress for this and we'll continue to work with members of both parties on this urgent issue."
According to DEA figures, overdose deaths linked to xylazine increased by 1,127 percent in the south of the country from 2020 to 2021 -- from 116 to 1,423 -- and were substantially higher in other regions too.
A kilogram (2.2 pounds) of xylazine powder can be purchased online from Chinese suppliers for just $6-$20 dollars, according to the DEA.
O.M.Souza--AMWN